中国组织工程研究
中國組織工程研究
중국조직공정연구
Journal of Clinical Rehabilitative Tissue Engineering Research
2014年
33期
5356-5360
,共5页
陈庆真%施明祥%刘盛飞%杜兰翔%厉江群
陳慶真%施明祥%劉盛飛%杜蘭翔%厲江群
진경진%시명상%류성비%두란상%려강군
组织构建%组织工程%神经生长因子%局部注射%周围神经%损伤
組織構建%組織工程%神經生長因子%跼部註射%週圍神經%損傷
조직구건%조직공정%신경생장인자%국부주사%주위신경%손상
nerve growth factor%peripheral nerves%evoked potentials,motor%evoked potentials,somatosensory
背景:鼠神经生长因子对神经损伤后的修复和再生有促进作用,但目前实验研究表明不同用药方式的作用尚有争议。<br> 目的:评价鼠神经生长因子不同给药方式治疗周围神经损伤的临床疗效。<br> 方法:52例周围神经损伤的患者随机分为2组,试验组27例局部注射鼠神经生长因子;对照组25例全身注射鼠神经生长因子,1次/d,一个疗程4周,比较两组患者神经功能的修复情况及疗效。<br> 结果与结论:与对照组相比,试验组优良率85%(23例),有效率93%(25例);对照组的优良率72%(18例),有效率84%(21例),两组优良率与有效率相比试验组显著优于对照组(P<0.05)。试验组中13例出现注射部位一过性痛,其中1例患者口服镇痛药物缓解;对照组中12例患者出现注射部位一过性疼痛,未做处理。结果提示,鼠神经生长因子治疗周围神经损伤安全有效,局部注射疗效优于全身用药。
揹景:鼠神經生長因子對神經損傷後的脩複和再生有促進作用,但目前實驗研究錶明不同用藥方式的作用尚有爭議。<br> 目的:評價鼠神經生長因子不同給藥方式治療週圍神經損傷的臨床療效。<br> 方法:52例週圍神經損傷的患者隨機分為2組,試驗組27例跼部註射鼠神經生長因子;對照組25例全身註射鼠神經生長因子,1次/d,一箇療程4週,比較兩組患者神經功能的脩複情況及療效。<br> 結果與結論:與對照組相比,試驗組優良率85%(23例),有效率93%(25例);對照組的優良率72%(18例),有效率84%(21例),兩組優良率與有效率相比試驗組顯著優于對照組(P<0.05)。試驗組中13例齣現註射部位一過性痛,其中1例患者口服鎮痛藥物緩解;對照組中12例患者齣現註射部位一過性疼痛,未做處理。結果提示,鼠神經生長因子治療週圍神經損傷安全有效,跼部註射療效優于全身用藥。
배경:서신경생장인자대신경손상후적수복화재생유촉진작용,단목전실험연구표명불동용약방식적작용상유쟁의。<br> 목적:평개서신경생장인자불동급약방식치료주위신경손상적림상료효。<br> 방법:52례주위신경손상적환자수궤분위2조,시험조27례국부주사서신경생장인자;대조조25례전신주사서신경생장인자,1차/d,일개료정4주,비교량조환자신경공능적수복정황급료효。<br> 결과여결론:여대조조상비,시험조우량솔85%(23례),유효솔93%(25례);대조조적우량솔72%(18례),유효솔84%(21례),량조우량솔여유효솔상비시험조현저우우대조조(P<0.05)。시험조중13례출현주사부위일과성통,기중1례환자구복진통약물완해;대조조중12례환자출현주사부위일과성동통,미주처리。결과제시,서신경생장인자치료주위신경손상안전유효,국부주사료효우우전신용약。
BACKGROUND:Mouse nerve growth factor can promote the repair and regeneration of injured nerves, but current experimental research shows that the effects of different treatment methods are stil controversial. <br> OBJECTIVE:To evaluate the effect of mouse nerve growth factor injection via different ways on the treatment of peripheral nerve injury. <br> METHODS:Total y 52 patients with peripheral nerve injury were randomly assigned into two groups:experimental group (local injection of mouse nerve growth factor, n=27) and control group (systemic administration of mouse nerve growth factor, n=25). The treatment was performed once a day, and lasted for 4 weeks. Then, the clinical efficacy and recovery of neurological function were compared. <br> RESULTS AND CONCLUSION:The good and effective rates were 85%(n=23) and 93%(n=25) in the experimental group, while 72%(n=18) and 84%(n=21) in the control group, respectively, which were significantly better in the experimental group than the control group (P<0.05). In the experimental group, 13 cases developed transient pain at injection site, including one case of remission undergoing oral analgesics;in the control group, 12 cases had transient pain at injection site, without any treatment. The results suggest that both local and total body injection of mouse nerve growth factor are safe and effective for treatment of peripheral nerve injury, but local injection is superior to systemic administration.